ketanserin has been researched along with Stasis Ulcer in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of a 2% ointment formulation of ketanserin, an S2-serotoninergic blocking agent, was investigated in a randomized double-blind clinical trial for its effect on the healing of wounds of patients with decubitus, venous, and ischemic skin ulcers." | 9.06 | Use of topical ketanserin in the treatment of skin ulcers: a double-blind study. ( Cauwenbergh, G; De Beule, K; De Doncker, P; Janssen, H; Janssen, PA; Lapière, CM; Lewi, P; Tytgat, HF, 1989) |
| "The use of a 2% ointment formulation of ketanserin, an S2-serotoninergic blocking agent, was investigated in a randomized double-blind clinical trial for its effect on the healing of wounds of patients with decubitus, venous, and ischemic skin ulcers." | 5.06 | Use of topical ketanserin in the treatment of skin ulcers: a double-blind study. ( Cauwenbergh, G; De Beule, K; De Doncker, P; Janssen, H; Janssen, PA; Lapière, CM; Lewi, P; Tytgat, HF, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rooman, RP | 1 |
| Janssen, H | 2 |
| Roelens, P | 1 |
| Janssen, PA | 1 |
| Cauwenbergh, G | 1 |
| De Doncker, P | 1 |
| De Beule, K | 1 |
| Lewi, P | 1 |
| Tytgat, HF | 1 |
| Lapière, CM | 1 |
3 trials available for ketanserin and Stasis Ulcer
| Article | Year |
|---|---|
Ketanserin promotes wound healing: clinical and preclinical results.
Topics: Aged; Chronic Disease; Double-Blind Method; Female; Granulation Tissue; Humans; Ketanserin; Leg Ulce | 1991 |
Double-blind placebo-controlled study with topical 2% ketanserin ointment in the treatment of venous ulcers.
Topics: Administration, Topical; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ketans | 1989 |
Use of topical ketanserin in the treatment of skin ulcers: a double-blind study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Isch | 1989 |